- Inhibits endothelin (ET) receptor
- Inhibits ET biosynthesis
- Inhibits NF-kB
Competition: Atrasentan (Abbott): Inhibits ET receptor only, slows tumor growth but does not induce apoptosis |
- More effective block of ET signaling
- Induces tumor cell apoptosis (cell death) that may lead to tumor regressions
|
